Raymond James Financial
WST icon

Raymond James Financial’s West Pharmaceutical WST Stock Holding History

Raymond James Financial’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.7M Sell
82,559
-19,889
-19% -$4.95M 0.01% 1448
2025
Q4 		$28.2M Sell
102,448
-18,002
-15% -$4.92M 0.01% 1207
2025
Q3 		$31.6M Sell
120,450
-6,221
-5% -$1.51M 0.01% 1104
2025
Q2 		$27.7M Sell
126,671
-106,796
-46% -$22.8M 0.01% 1133
2025
Q1 		$52.3M Buy
233,467
+11,685
+5% +$3.22M 0.02% 699
2024
Q4 		$72.6M Buy
+221,782
New +$69.8M 0.03% 542

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial's WST Position: Q1 2026 in Review

Raymond James Financial reduced its West Pharmaceutical (WST) stake by 19% in Q1 2026, selling an estimated $4.95M and leaving 82,559 shares worth $20.7M. The position accounts for 0.01% of the portfolio, ranked #1448.

Raymond James Financial first reported a position in WST in Q4 2024 and has held it in 6 quarters since. The position peaked at $72.6M in Q4 2024. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Raymond James Financial held 82,559 shares of West Pharmaceutical worth $20.7M as of Q1 2026.
  • Raymond James Financial sold 19,889 West Pharmaceutical shares in Q1 2026, an estimated $4.95M.
  • West Pharmaceutical made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1448 holding.
  • Raymond James Financial first reported a position in West Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's West Pharmaceutical position peaked at $72.6M in Q4 2024.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.